Accenture, Google Cloud boost life sciences market

Accenture and Google Cloud have teamed up to make the latter the cloud technology provider for the former’s Intient life sciences industry platform. 

The new, multi-year agreement brings Google’s cloud and artificial intelligence capabilities together with Accenture’s life sciences services and platforms, and is intended to help life sciences organisations make their data more accessible, secure and valuable.

The Intient platform provides life sciences organisations with end-to-end capabilities from discovery and research to clinical development and the delivery of treatments. 

“Inteint will advance Accenture’s and Google Cloud’s shared mission to empower life sciences organisations with intelligent solutions that help bring innovative treatments to patients around the world, with greater speed, safety, and efficacy,” said Simon Eaves, group chief executive of products at Accenture.

Google Cloud’s architecture supports open source technology that will enable Accenture to expand the capabilities of Intient by allowing partners, independent software vendors, and content providers to rapidly develop and provide additional solutions that extend the value of the platform.

“Our shared goal is to accelerate developments in treatments by leveraging powerful Google Cloud capabilities, such as AI and data analytics, to gain insights that correlate symptoms, events, and treatments in new and unexpected ways,” said Tariq Shaukat, president at Google Cloud.

The agreement is an extension of the partnership between Accenture and Google built over the last eight years. A key milestone in the relationship was the July 2018 launch of the Accenture Google Cloud Business Group, which helps companies use Google Cloud technology to deliver superior customer experiences and accelerate their digital transformation journeys.